DK193086A - 7-substituerede bicycliske pyrazolidinoner, fremgangsmaade til fremstilling heraf og mellemprodukter til brug ved fremgangsmaaden - Google Patents
7-substituerede bicycliske pyrazolidinoner, fremgangsmaade til fremstilling heraf og mellemprodukter til brug ved fremgangsmaaden Download PDFInfo
- Publication number
- DK193086A DK193086A DK193086A DK193086A DK193086A DK 193086 A DK193086 A DK 193086A DK 193086 A DK193086 A DK 193086A DK 193086 A DK193086 A DK 193086A DK 193086 A DK193086 A DK 193086A
- Authority
- DK
- Denmark
- Prior art keywords
- substituted
- group
- alkyl
- arylalkyl
- phenyl
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 239000000543 intermediate Substances 0.000 title abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 17
- 229910052739 hydrogen Inorganic materials 0.000 abstract 10
- 239000001257 hydrogen Substances 0.000 abstract 10
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 9
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 8
- 150000002431 hydrogen Chemical group 0.000 abstract 8
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 8
- -1 bicyclic pyrazolidinone compound Chemical class 0.000 abstract 5
- 125000002252 acyl group Chemical group 0.000 abstract 3
- 150000001767 cationic compounds Chemical class 0.000 abstract 3
- 229910001411 inorganic cation Inorganic materials 0.000 abstract 3
- 150000002892 organic cations Chemical class 0.000 abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 abstract 2
- 231100000252 nontoxic Toxicity 0.000 abstract 2
- 230000003000 nontoxic effect Effects 0.000 abstract 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium group Chemical group [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 abstract 1
- 230000000845 anti-microbial effect Effects 0.000 abstract 1
- 239000004599 antimicrobial Substances 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 125000001246 bromo group Chemical group Br* 0.000 abstract 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 abstract 1
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 125000001153 fluoro group Chemical group F* 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000002346 iodo group Chemical group I* 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000005544 phthalimido group Chemical group 0.000 abstract 1
- 125000006239 protecting group Chemical group 0.000 abstract 1
- NDGRWYRVNANFNB-UHFFFAOYSA-N pyrazolidin-3-one Chemical class O=C1CCNN1 NDGRWYRVNANFNB-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000004953 trihalomethyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/06—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D231/08—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with oxygen or sulfur atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6503—Five-membered rings
- C07F9/65031—Five-membered rings having the nitrogen atoms in the positions 1 and 2
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72902185A | 1985-04-30 | 1985-04-30 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK193086D0 DK193086D0 (da) | 1986-04-28 |
| DK193086A true DK193086A (da) | 1987-01-20 |
Family
ID=24929253
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK193086A DK193086A (da) | 1985-04-30 | 1986-04-28 | 7-substituerede bicycliske pyrazolidinoner, fremgangsmaade til fremstilling heraf og mellemprodukter til brug ved fremgangsmaaden |
Country Status (16)
| Country | Link |
|---|---|
| US (4) | US4716232A (el) |
| EP (1) | EP0202046B1 (el) |
| JP (2) | JPH0759582B2 (el) |
| KR (1) | KR880001092B1 (el) |
| CN (1) | CN86103619A (el) |
| AT (1) | ATE60605T1 (el) |
| AU (1) | AU5675586A (el) |
| CA (1) | CA1274832A (el) |
| DE (1) | DE3677253D1 (el) |
| DK (1) | DK193086A (el) |
| ES (1) | ES8801833A1 (el) |
| GR (1) | GR861118B (el) |
| HU (1) | HUT40660A (el) |
| IL (1) | IL78634A0 (el) |
| PT (1) | PT82468B (el) |
| ZA (2) | ZA863170B (el) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL78634A0 (en) * | 1985-04-30 | 1986-08-31 | Lilly Co Eli | 7-substituted bicyclic pyrazolidinones |
| US4940718A (en) * | 1985-04-30 | 1990-07-10 | Eli Lilly And Company | 7-substituted bicyclic pyrazolidinones, pharmaceutical compositions and use |
| US4935536A (en) * | 1987-05-21 | 1990-06-19 | Millipore Corporation | Protecting groups for asparagine and glutamine in peptide synthesis |
| IL86095A0 (el) * | 1987-09-30 | 1988-09-30 | Lilly Co Eli | |
| US5011938A (en) * | 1989-10-02 | 1991-04-30 | Eli Lilly And Company | 7-substituted bicyclic pyrazolidinones |
| US5430145A (en) * | 1990-10-18 | 1995-07-04 | Merrell Dow Pharmaceuticals Inc. | Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
| US5308841A (en) * | 1990-12-21 | 1994-05-03 | Merrell Dow Pharmaceuticals Inc. | Amino and nitro containing tricyclic compounds useful as inhibitors of ACE |
| US5457196A (en) * | 1991-09-27 | 1995-10-10 | Merrell Dow Pharmaceuticals Inc. | 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE |
| US5455242A (en) * | 1991-09-27 | 1995-10-03 | Merrell Dow Pharmaceuticals Inc. | Carboxyalkyl tricyclic derivatives useful as inhibitors of enkephalinase and ace |
| DK0534363T3 (da) * | 1991-09-27 | 1997-09-22 | Merrell Pharma Inc | 2-substituerede indan-2-mercaptoacetylamid-forbindelse med inhiberende virkning på enkephalinase og ACE. |
| CA2130116C (en) * | 1992-02-14 | 1998-04-07 | Gary A. Flynn | Aminoacetylmercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
| ATE182892T1 (de) * | 1992-05-15 | 1999-08-15 | Merrell Pharma Inc | Mercaptoacetylamide von pyridazo(1,2-a>(1,2>- diazepin -derivaten als eukephalinase und ace- inhibitoren |
| US5420271A (en) * | 1992-08-24 | 1995-05-30 | Merrell Dow Pharmaceuticals, Inc. | 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase |
| US5470845A (en) * | 1992-10-28 | 1995-11-28 | Bristol-Myers Squibb Company | Methods of using α-phosphonosulfonate squalene synthetase inhibitors including the treatment of atherosclerosis and hypercholesterolemia |
| CA2107644A1 (en) * | 1992-10-28 | 1994-04-29 | David R. Magnin | .alpha.-phosphonosulfonae squalene synthetase inhibitors and methd |
| CA2146238C (en) * | 1992-10-30 | 2001-03-13 | Gary A. Flynn | Novel mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ace |
| PT750631E (pt) * | 1994-02-14 | 2000-07-31 | Merrell Pharma Inc | Novos derivados de dissulfureto de mercapto-aacetilamido-1,3,4,5-tetra-hidro-benzo¬c)azepin-3-ona uteis como inibidores de encefalinase e ace |
| US5530013A (en) * | 1994-02-14 | 1996-06-25 | American Home Products Corporation | Venlafaxine in the inducement of cognition enhancement |
| CN1142831A (zh) * | 1994-02-14 | 1997-02-12 | 默里尔药物公司 | 用作脑啡肽酶和ace抑制剂的新的2-取代的1，2-二氢化茚-2-巯基乙酰胺二硫化物衍生物 |
| ATE177098T1 (de) * | 1994-02-14 | 1999-03-15 | Merrell Pharma Inc | Mercaptoacetylamid disulfidderivate als enkephalinase und ace inhibitoren |
| WO1995021840A1 (en) * | 1994-02-14 | 1995-08-17 | Merrell Pharmaceuticals Inc. | Novel indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase |
| US5484783A (en) * | 1994-03-24 | 1996-01-16 | Merrell Dow Pharmaceuticals Inc. | Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide and benzazapine derivatives |
| JPH10503468A (ja) * | 1994-03-24 | 1998-03-31 | メリル・フアーマシユウテイカルズ・インコーポレイテツド | 低コレステロール血性、抗アテローム性動脈硬化性および低トリグリセライド血性のメルカプトアセチルアミドジスルフィド誘導体 |
| DE69514912T2 (de) * | 1994-03-24 | 2000-10-05 | Merrell Pharmaceuticals Inc., Cincinnati | Hypocholesterolemische, antiatherosklerotische und hypotriglyceridemische verwendung von aminoacetylmercapto derivaten |
| US5447922A (en) * | 1994-08-24 | 1995-09-05 | Bristol-Myers Squibb Company | α-phosphonosulfinic squalene synthetase inhibitors |
| US5786448A (en) * | 1996-11-07 | 1998-07-28 | Trega Biosciences, Inc. | Combinatorial libraries of cyclic urea and cyclic thiourea derivatives and compounds therein |
| GB0119305D0 (en) | 2001-04-12 | 2001-10-03 | Aventis Pharma Gmbh | Mercaptoacetylamide derivatives,a process for their preparation and their use |
| UY32826A (es) | 2009-08-04 | 2011-02-28 | Takeda Pharmaceutical | Compuestos heterocíclicos |
| CN106883236B (zh) * | 2017-03-17 | 2018-12-04 | 浙江大学 | 一种制备含硫的n，n-双环吡唑烷酮类衍生物的方法 |
| CN115286635B (zh) * | 2022-08-22 | 2023-10-24 | 河南师范大学 | 一种手性并环吡唑啉酮类化合物的合成方法 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3065224A (en) | 1955-06-24 | 1962-11-20 | Bayer Ag | Process for the production of addition products of organic isocyanates and organic carbodiimides |
| US2938892A (en) | 1958-10-10 | 1960-05-31 | Little Inc A | Amides and process of preparing same with a monocarbodhmide |
| AR206201A1 (es) | 1972-06-29 | 1976-07-07 | Ciba Geigy Ag | Procedimiento para la obtencion de compuestos de acido 7beta-amino-3-cefem-3-01-4-carboxilico0-substituidos |
| GB1415910A (en) * | 1973-03-21 | 1975-12-03 | Kyowa Hakko Kogyo Kk | Benzothiazoles |
| DD110868A1 (el) * | 1974-04-03 | 1975-01-12 | ||
| GB1472052A (en) * | 1975-02-14 | 1977-04-27 | Pliva Pharm & Chem Works | Preparation of d-penicillamine and substituted 3-pyrazoline- 5-ones |
| GB1591439A (en) | 1976-10-01 | 1981-06-24 | Glaxo Operations Ltd | 7-syn (oxyimino -acylamido) cephalosporins |
| DE2714880A1 (de) | 1977-04-02 | 1978-10-26 | Hoechst Ag | Cephemderivate und verfahren zu ihrer herstellung |
| US4128425A (en) * | 1977-05-06 | 1978-12-05 | Polaroid Corporation | Photographic developers |
| DD143617A1 (de) | 1979-05-14 | 1980-09-03 | Helmut Dorn | Verfahren zur herstellung von 2-nitro-und 2-amino-5-oxo-perhydro-pyrazolo eckige klammer auf 1,2-a eckige klammer zu pyrazolen |
| DE2931673A1 (de) * | 1979-08-04 | 1981-02-26 | Basf Ag | Pyrazolin-5-on-yl-methyl-(di)thiophosphorsaeureester, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung von schaedlingen |
| GB2073740A (en) * | 1980-03-03 | 1981-10-21 | Wellcome Found | Pyrazolidinones |
| US4396619A (en) | 1981-09-08 | 1983-08-02 | Eli Lilly And Company | Cephalosporin betaines |
| GB2128984B (en) * | 1982-05-12 | 1985-05-22 | Hoffmann La Roche | Diaza-bicyclic compounds |
| US4465679A (en) * | 1983-01-31 | 1984-08-14 | Usv Pharmaceutical Corporation | 1,2-Diaza-3-one compounds, their use in treating hypertension and pharmaceutical compositions thereof |
| AU575854B2 (en) | 1983-10-04 | 1988-08-11 | Shionogi & Co., Ltd. | 7beta-(carboxyalkenamido) cephalosporins |
| KR880000435B1 (ko) | 1985-04-30 | 1988-03-24 | 일라이 릴리 앤드 캄파니 | 피라졸리디늄 일리드 및 그의 제조방법 |
| HU198298B (en) | 1985-04-30 | 1989-09-28 | Lilly Co Eli | Process for producing 4-substituted pyrazolidinones |
| IL78634A0 (en) * | 1985-04-30 | 1986-08-31 | Lilly Co Eli | 7-substituted bicyclic pyrazolidinones |
-
1986
- 1986-04-28 IL IL78634A patent/IL78634A0/xx unknown
- 1986-04-28 HU HU861763A patent/HUT40660A/hu unknown
- 1986-04-28 PT PT82468A patent/PT82468B/pt unknown
- 1986-04-28 ZA ZA863170A patent/ZA863170B/xx unknown
- 1986-04-28 DK DK193086A patent/DK193086A/da not_active Application Discontinuation
- 1986-04-28 CA CA000507777A patent/CA1274832A/en not_active Expired - Lifetime
- 1986-04-28 AT AT86303174T patent/ATE60605T1/de not_active IP Right Cessation
- 1986-04-28 KR KR1019860003251A patent/KR880001092B1/ko not_active IP Right Cessation
- 1986-04-28 AU AU56755/86A patent/AU5675586A/en not_active Abandoned
- 1986-04-28 DE DE8686303174T patent/DE3677253D1/de not_active Expired - Lifetime
- 1986-04-28 ES ES554463A patent/ES8801833A1/es not_active Expired
- 1986-04-28 EP EP86303174A patent/EP0202046B1/en not_active Expired - Lifetime
- 1986-04-28 GR GR861118A patent/GR861118B/el unknown
- 1986-04-28 CN CN198686103619A patent/CN86103619A/zh active Pending
- 1986-04-30 JP JP61100817A patent/JPH0759582B2/ja not_active Expired - Lifetime
- 1986-05-14 US US06/862,913 patent/US4716232A/en not_active Expired - Fee Related
- 1986-05-14 US US06/862,918 patent/US4734504A/en not_active Expired - Lifetime
- 1986-05-14 US US06/862,909 patent/US4734505A/en not_active Expired - Lifetime
- 1986-10-28 JP JP61258084A patent/JPS63112583A/ja active Pending
-
1987
- 1987-10-29 US US07/114,897 patent/US4795815A/en not_active Expired - Lifetime
-
1988
- 1988-04-13 ZA ZA882604A patent/ZA882604B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUT40660A (en) | 1987-01-28 |
| CA1274832A (en) | 1990-10-02 |
| ZA863170B (en) | 1987-12-30 |
| PT82468B (en) | 1988-03-23 |
| US4795815A (en) | 1989-01-03 |
| US4716232A (en) | 1987-12-29 |
| EP0202046B1 (en) | 1991-01-30 |
| ES8801833A1 (es) | 1988-02-16 |
| KR880001092B1 (ko) | 1988-06-23 |
| JPS61254589A (ja) | 1986-11-12 |
| IL78634A0 (en) | 1986-08-31 |
| ES554463A0 (es) | 1988-02-16 |
| AU5675586A (en) | 1986-11-13 |
| JPS63112583A (ja) | 1988-05-17 |
| ZA882604B (en) | 1989-12-27 |
| PT82468A (en) | 1986-05-01 |
| CN86103619A (zh) | 1986-10-29 |
| JPH0759582B2 (ja) | 1995-06-28 |
| ATE60605T1 (de) | 1991-02-15 |
| DE3677253D1 (de) | 1991-03-07 |
| DK193086D0 (da) | 1986-04-28 |
| GR861118B (en) | 1986-08-18 |
| US4734505A (en) | 1988-03-29 |
| EP0202046A1 (en) | 1986-11-20 |
| KR860008181A (ko) | 1986-11-12 |
| US4734504A (en) | 1988-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK193086A (da) | 7-substituerede bicycliske pyrazolidinoner, fremgangsmaade til fremstilling heraf og mellemprodukter til brug ved fremgangsmaaden | |
| DK0874824T3 (da) | Trisubstituerede phenylderivater nyttige som PDE IV inhibitorer | |
| HUP0100051A2 (hu) | Antimikrobiális kinolonok, ezeket tartalmazó készítmények és alkalmazásuk | |
| AR035871A1 (es) | Procedimiento para preparar derivados de 9-desoxo-9a-aza-9a-homoeritromicina a 4''-sustituidos, intermediario y procedimiento para la preparacion del mismo | |
| MY132507A (en) | Process for substituted pyridines | |
| NO305595B1 (no) | Fenoksyfenyl-cyklopentyl-hydroksyurinstoffer, farmas°ytisk preparat og anvendelse derav | |
| RS49829B (sr) | Postupak i intermedijeri za proizvodnju piridin-2,3-dikarboksilat jedinjenja | |
| EA200101109A1 (ru) | Производные 1-трифторметил-4-гидрокси-7-пиперидинил-аминометилхромана | |
| GB0003257D0 (en) | Heterocyclic compounds and their therapeutic use | |
| DE69316392D1 (de) | Azanoradamantane | |
| YU63392A (sh) | Bis(oksi) jedinjenja i postupak za njihovo dobijanje | |
| DK428087A (da) | Dihydropyridin-5-phosphonsyre-cyclopropylenester | |
| NZ336969A (en) | Substituted 4-aminoalkoxy-1H-benzimidazole derivatives useful as dopamine autoreceptor (D2) agonists | |
| PL307851A1 (en) | 4-keto azetidine sulphonic-2 amides and their salts, method of obtaining them and their application | |
| YU46886B (sh) | Postupak za dobijanje haloalkil tiazola | |
| TH34367A (th) | สารต้านจุลชีพอะมิโนและไธโอแอลคิล เบนซอกแซซีนที่มีหมู่แทนที่ตำแหน่ง 2- | |
| NO308304B1 (no) | Nye 5H-thiazol[3,2-a]pyrimidin-5-on derivater, anvendelse derav for fremstilling av farmasøytiske sammensetninger, farmasøytiske sammensetninger inneholdende derivatene, samt et preparat til behandling av psykose, schizofreni og angst |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHB | Application shelved due to non-payment |